Indoco Remedies falls over 15% on import alert for Goa unit

The stock tanked 16% to Rs 208.50, also its 52-week low on the NSE in early morning trade

Indoco Remedies tanked 16% to Rs 208.50, also its 52-week low on the National Stock Exchange (NSE) in early morning trade after the company said it has received a warning letter from the US health regulator for its Goa plant.

“The United States Food and Drug Administration (USFDA) had inspected the company's drug manufacturing facility in Goa from August 31, 2016 to September 4, 2016. As an outcome of this inspection, the facility received 6 observations in Form 483, which do not pertain to data integrity”, Indoco Remedies said in a filing to BSE.

Based on the review